The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor – an alternative gene therapy
- 11 November 2004
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 64 (3) , 505-511
- https://doi.org/10.1016/j.mehy.2004.07.039
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Circatrigintan Cycle of Salivary Testosterone in Human MaleBiological Rhythm Research, 2003
- Experimental angiogenesis of arterial vasa vasorumCell and tissue research, 2002
- Gene therapy for cystic fibrosisThe Journal of Gene Medicine, 2001
- Angiogenesis TherapyCirculation, 2001
- Role of vascular endothelial growth factor in regulation of physiological angiogenesisAmerican Journal of Physiology-Cell Physiology, 2001
- FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibitionTrends in Pharmacological Sciences, 2001
- Vascular endothelial growth factor enhances atherosclerotic plaque progressionNature Medicine, 2001
- Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazardsCardiovascular Research, 2001
- Clinical applications of angiogenic growth factors and their inhibitorsNature Medicine, 1999
- Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188Nature Medicine, 1999